Journal of Vaccines & Vaccination

Cecílio P, Oliveira F, Cordeiro-da-Silva A. Vaccines for human leishmaniasis: where do we stand and what is still missing. Leishmaniases as reemerging diseases. Rijeka: IntechOpen. 2018: 59-93.  

Collins C, Lorenzen N, Collet B. DNA vaccination for finfish aquaculture. Fish & shellfish immunology. 2019;85: 106-125.  

Earla P. Pediatric Infectious Diseases. Research and Reviews: Research Journal of Biology. 2016

Natta A. Infectious Disease: An Overview of its Causes, Symptoms and Treatment. Journal of Medical and Health Sciences. 2016.    

Wang WH, Erazo EM, Ishcol MR, Lin CY, Assavalapsakul W, Thitithanyanont A, Wang SF. Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: a systemic literature review. Journal of International Medical Research. 2019.  

Lai CC, Cheng YC, Chen PW, Lin TH, Tzeng TT, Lu CC, Lee MS, Hu AY. Process development for pandemic influenza VLP vaccine production using a baculovirus expression system. Journal of biological engineering. 2019;13: 78.  

Isakova-Sivak I, Rudenko L. Tackling a novel lethal virus: a focus on H7N9 vaccine development. Expert review of vaccines. 2017;16: 709-721.  

Pencheva D, Genova-Kalou P, Bryaskova R. COMPARATIVE STUDY OF METHODS FOR INACTIVATION OF VACCINES IN DEVELOPMENT PROCESS OF VETERINARY “GHOST” VACCINE. Comptes rendus de l’Académie bulgare des Sciences. 2016;69.  

Nyundo S, Adamson E, Rowland J, Palermo PM, Matiko M, Bettinger GE, Wambura P, Morrill JC, Watts D. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania. Onderstepoort Journal of Veterinary Research. 2019;86: 1-8.  

Boumart Z, Daouam S, Bamouh Z, Jazouli M, Tadlaoui KO, Dungu B, et al. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves. Vaccine. 2019;37: 1642-1650.  

Kuranasree P. A brief study on hemorrhagic septicemia. Res Rev J Vet Sci. 2016;2: 30-37.  

Fawzy M, Helmy YA. The one health approach is necessary for the control of rift valley fever infections in Egypt: a comprehensive review. Viruses. 2019;11: 139.  

Daouam S, Ghzal F, Naouli Y, Tadlaoui KO, Ennaji MM, Oura C, Harrak ME. Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels. BMC veterinary research. 2016;12: 154.  

Dungu B, Lubisi BA, Ikegami T. Rift Valley fever vaccines: current and future needs. Current opinion in virology. 2018;29: 8-15.  

Faburay B, LaBeaud AD, McVey DS, Wilson WC, Richt JA. Current status of Rift Valley fever vaccine development. Vaccines. 2017;5: 29.  

KHROMOVA EA , AKHMATOVA NK, AKHMATOVA EA , KOSTINOVA AM , CHERDANTSEV AP , SAVISKO AA. INFLUENCE OF VACCINATION AGAINST INFLUENZA ON PREGNANCY, DEVELOPMENT OF THE FETUS AND NEWBORNS. 2017.  

Petrovich KM, Petrovich CA, Dmitrievna SA, Kimovna AN, Mikhailovna KA, Alexandrovna PD, Borisovna PV, Dmitrievich PA, Victorovich ZA, Vladimirovich TY. The Efficacy of Immunoadjuvant-Containing Influenza Vaccines in Pregnancy. Vaccines. 2017: 67.  

Khromova EA, Akhmatova EA, Kostinova AM, Cherdantsev AP, Savisko AA, Akhmatova NK. Impact of influenza vaccination on the course of pregnancy and on fetal and neonatal development. Obstet Gynecol. 2017;7: 12-17.  

Natta A. Infectious Disease: An Overview of its Causes, Symptoms and Treatment. Journal of Medical and Health Sciences. 2016  

Natta A. Infectious Disease: An Overview of its Causes, Symptoms and Treatment. Journal of Medical and Health Sciences. 2016